Ron Rosenfeld
机构: Professor of Pediatrics. Stanford University and Oregon Health and Sciences University
每年引用次数
引用次数
引用: 47,280
H-指数: 120
I10-指数 : 507
出版物: 957
[Clinical and biochemical characteristics of growth hormone receptor insufficiency (Larone's syndrome)].
H Gevara-Aguirre , U Bloom , R Rosenfeld , A Rozenblum
Problemy e̊ndokrinologii 40 ( 2) 74 -77
1994
Conclusions: a consensus statement on growth hormone therapy.
R Rosenfeld , Z Hochberg , K Albertsson-Wikland , PD Gluckman
Acta Paediatrica 367 ( 367) 177 -178
2
1990
Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society
A Shimatsu , PH Sonksen , AM Kappelgaard , MN Pollak
The Journal of Clinical Endocrinology and Metabolism 86 ( 5) 1868 -1870
135
2001
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
P Cohen , DM Peehl , R Rosenfeld ,
British Journal of Cancer 78 ( 4) 554 -556
10
1998
Synthetic hGH causes both increased somatomedin levels and insulin resistance in humans
R L Hintz , R Rosenfeld , D Wilson , A Bennett
Pediatric Research 15 ( 12) 1541 -1541
3
1981
Acute and chronic somatomedin-C response to growth hormone: Evaluation of correlation with age and growth rate
R Rosenfeld , S Kemp , R Hintz
Pediatric Research 15 ( 12) 1553 -1553
1981
SHORT TERM METABOLIC CHANGES AND LONG TERM RESPONSE TO RECOMBINANT IGF-I (rhIGF-I) THERAPY IN A NORTH AMERICAN CHILD WITH GH INSENSITIVITY (GHIS; LARON SYNDROME)
P M Martha , C Johnston , P Cohen , R Rosenfeld
Pediatric Research 33 ( 5) S49 -S49
4
1993
Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience.
S L Blethen , D B Allen , D Graves , G August
The Journal of Clinical Endocrinology & Metabolism 81 ( 5) 1704 -1710
214
1996
The growth hormone and somatomedin axis in short children with osteogenesis imperfecta
JOAN C Marini , STEPHANIE Bordenick , GALE Heavner , SUSAN Rose
Journal of Clinical Endocrinology & Metabolism 76 ( 1) 251 -256
73
1993
The quality-of-life benefits of growth hormone-increased final height: What do we know?-Discussion of papers by Drs. MacGillivray and Sandberg
R Rosenfeld , M MacGillivray , A Carrel , D Sandberg
ENDOCRINOLOGIST 11 ( 4) 12S -13S
2001
Insulin, IGFs, and their Receptors: Molecular, Cellular, and Functional Aspects
GI Bell , D Clemmons , A Efstratiadis , D Ishii
Avances recientes en la investigación del crecimiento: perspectivas nutricionales, moleculares y endocrinas
M Gillman , P Gluckman , R Rosenfeld
Nestlé Nutr Inst Workshop Ser 71 1 -23
1
2011
Relationship between phenotype and genotype in growth hormone insensitivity syndrome-Discussion
P Rotwein , M Savage , R Ross , K Woods
ACTA PAEDIATRICA 88 163 -163
1999
Natural history of growth hormone receptor deficiency-Discussion
R Rosenfeld , A Rosenbloom , P Saenger
ACTA PAEDIATRICA 88 157 -157
1999
Growth hormone treatment until genetic potential is reached-Discussion of Allen and Kappy papers
R Rosenfeld , M Kappy , D Diekema , M Pauly
ENDOCRINOLOGIST 11 ( 4) 62S -65S
2001
Is maximizing height good parenting? Discussion of paper by Dr. Diekema
R Rosenfeld , D Diekema , D Allen , D Sandberg
ENDOCRINOLOGIST 11 ( 4) 70S -71S
2001
Oregon's treatment of human growth hormone therapy: A description and evaluative analysis-Discussion of paper by Dr. Menzel
D Cook , P Menzel , M MacGillivray , D Sandberg
ENDOCRINOLOGIST 11 ( 4) 45S -46S
2001
Genetic variations in candidate genes in idiopathic short stature subjects from the epigrow study: analysis of cases versus controls
M Bonnemaire , A Thiagalingam , E Pham , L Naudin
Hormone Research 76 30 -30
1
2011
Is the treatment/enhancement distinction useful? Discussion of paper by Dr. Fost
D Brock , N Fost , D Allen , R Rosenfeld
ENDOCRINOLOGIST 11 ( 4) 75S -77S
2001
Discovering anaemia at child health clinics
MC Ayuso , MC Ramos , MC Bello , A Jimenez
Annu Rev Genet 16 193 -224
1982